Home › Deadlines › October 2027

Grant deadlines: October 2027

29 federal funding opportunities close in October 2027. Sorted by deadline, earliest first.

• Home Study and Post-Release Services for Unaccompanied Alien Children​​
  OpenHHS-2026-ACF-ORR-ZU-0019 · Administration for Children and Families - ORR · closes October 1, 2027
• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
  OpenRFA-NS-27-015 · National Institutes of Health · closes October 4, 2027
• Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
  OpenPAR-25-248 · National Institutes of Health · closes October 8, 2027
• Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
  OpenPAR-25-327 · National Institutes of Health · closes October 8, 2027
• NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
  OpenRFA-DC-25-002 · National Institutes of Health · closes October 12, 2027
• NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
  OpenPAR-25-135 · National Institutes of Health · closes October 14, 2027
• NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
  OpenPAR-25-313 · National Institutes of Health · closes October 14, 2027
• Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
  OpenPAR-25-183 · National Institutes of Health · closes October 15, 2027
• Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
  OpenPAR-25-285 · National Institutes of Health · closes October 15, 2027
• Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
  OpenPAR-25-177 · National Institutes of Health · closes October 15, 2027
• Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
  OpenPAR-25-181 · National Institutes of Health · closes October 15, 2027
• Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
  OpenPAR-25-178 · National Institutes of Health · closes October 15, 2027
• Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
  OpenPAR-25-179 · National Institutes of Health · closes October 15, 2027
• Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
  OpenPAR-25-182 · National Institutes of Health · closes October 15, 2027
• First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
  OpenPAR-25-180 · National Institutes of Health · closes October 15, 2027
• Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
  OpenPAR-25-184 · National Institutes of Health · closes October 15, 2027
• NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
  OpenPAR-25-120 · National Institutes of Health · closes October 15, 2027
• NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
  OpenPAR-25-357 · National Institutes of Health · closes October 16, 2027
• NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
  OpenPAR-25-343 · National Institutes of Health · closes October 18, 2027
• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  OpenPAR-25-296 · National Institutes of Health · closes October 19, 2027
• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
  OpenRFA-CA-27-019 · National Institutes of Health · closes October 19, 2027
• Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
  OpenPAR-25-225 · National Institutes of Health · closes October 20, 2027
• Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
  OpenPAR-25-059 · National Institutes of Health · closes October 20, 2027
• Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
  OpenPAR-25-060 · National Institutes of Health · closes October 20, 2027
• Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
  OpenPAR-25-103 · National Institutes of Health · closes October 25, 2027
• Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
  OpenPAR-25-104 · National Institutes of Health · closes October 25, 2027
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
  OpenPAR-25-353 · National Institutes of Health · closes October 25, 2027
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
  OpenPAR-25-352 · National Institutes of Health · closes October 25, 2027
• Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
  OpenPAR-27-078 · National Institutes of Health · closes October 25, 2027